Скачать или смотреть Lilly-backed scheme aims to help UK improve obesity care

In today’s headlines - 12 August 2025:

Tens of thousands of NHS patients living with obesity could get help to reduce their weight through a partnership between the UK and Eli Lilly.

An alliance between Apple and FuturHealth will combine GLP-1 weight-loss treatment with the tech giant's Fitness+ subscription.

Novartis' ianalumab has delivered another win in primary immune thrombocytopenia, its second win in autoimmune diseases in 24 hours.

IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless.

Bayer has joined the throng of drugmakers developing KRAS-targeting drugs for cancer, via an alliance with San Diego biotech Kumquat.

#news #pharma #pharmanews #pharmainnovation #pharmaindustry #lifesciences #biotechnews #biopharma #drugdevelopment #oncology #cancertreatment #cancerresearch #iobiotech #cancervaccines #melanoma #novartis #autoimmunedisease #apple #applefitness #futurhealth #glp1medications #weightloss #nhs #ukgoverment #elililly #obesity